JNJ-39393406
id:
jnj-39393406-286-14891667
title:
JNJ-39393406
text:
JNJ-39393406 is an experimental medication which is under development by Janssen Pharmaceutica, a division of Johnson & Johnson, for the treatment of depressive disorders and smoking withdrawal. It acts as a selective positive allosteric modulator of the α7 nicotinic acetylcholine receptor (nAChR). It does not act on the α4β2 or α3β4 nAChRs or the serotonin 5-HT3 receptor, and does not interact with a panel of 62 other receptors and enzymes. The drug has been found to lower the agonist and nicot
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/JNJ-39393406
date created:
date modified:
2023-12-03T22:20:04Z
main entity:
{"identifier":"Q27289838","url":"https://www.wikidata.org/entity/Q27289838"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/70/JNJ-39393406.svg","width":1600,"height":960}
fields total:
13
integrity:
15